Yang Huanfeng is the founder of Oricell Therapeutics. Oricell Therapeutics has raised $110M in total funding. Based in Shanghai, China.
Huanfeng Yang, Ph.D., is the CEO of Oricell Therapeutics, a Shanghai-based pharmaceutical company established in 2015. Oricell specializes in the development of tumor cellular immunotherapeutics, particularly CAR-T therapies for solid tumors. The company has raised significant funding, including over $110 million in a pre-IPO round, a $125 million Series B in 2022, and a $45 million Series B1 in 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library